Finance

Lists
NWBO:OTCMKTS
Northwest Biotherapeutics Inc
US$ ०.१६
-१.५३%
(-०.००२५) 1D
अक्टोबर १४, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NWBO...
Open
US$ ०.१६
High
US$ ०.१७
Low
US$ ०.१६
Mkt. cap
२७.७१ करोड
Avg. vol.
३८.९३ लाख
Volume
५३.३५ लाख
52-wk high
US$ ०.३४
52-wk low
US$ ०.१४
EPS
-US$ ०.०३
Beta
-०.६२
Shares outstanding
१.७१ अरब
No. of employees
१०५
Open
US$ ०.१६
High
US$ ०.१७
Low
US$ ०.१६
Mkt. cap
२७.७१ करोड
Avg. vol.
३८.९३ लाख
Volume
५३.३५ लाख
52-wk high
US$ ०.३४
52-wk low
US$ ०.१४
EPS
-US$ ०.०३
Beta
-०.६२
Shares outstanding
१.७१ अरब
No. of employees
१०५
News stories
From web sources and news partners
Profile
Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton. Wikipedia
About Northwest Biotherapeutics Inc
CEO-
Employees१०५
Founded१९९८ जनवरी १
Headquarters-
Sector-
Websitenwbio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२.०० लाख
६.७२ लाख
४.९४ लाख
८.०७ लाख
Cost of goods sold
७४.५० लाख
५५.५४ लाख
४८.५८ लाख
५७.०५ लाख
Cost of revenue
७४.५० लाख
५५.५४ लाख
४८.५८ लाख
५७.०५ लाख
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
७०.७० लाख
८६.२२ लाख
६५.३६ लाख
६७.०७ लाख
Operating expense
७०.७० लाख
८६.२२ लाख
६५.३६ लाख
६७.०७ लाख
Total operating expenses
१.४५ करोड
१.४२ करोड
१.१४ करोड
१.२४ करोड
Operating income
-१.४३ करोड
-१.३५ करोड
-१.०९ करोड
-१.१६ करोड
Other non operating income
-३४.५० लाख
११.४४ लाख
९५.३० लाख
६४.०० हजार
EBT including unusual items
-२.६८ करोड
८.५१ लाख
-३०.६९ लाख
-९२.२१ लाख
EBT excluding unusual items
-२.१२ करोड
-१.४८ करोड
-५०.६० लाख
-१.३५ करोड
Income tax expense
-
-५.३७ लाख
-
-
Effective tax rate
-
-६३.१०%
-
-
Other operating expenses
-
-
-
-
Net income
-२.६८ करोड
१३.८८ लाख
-३०.६९ लाख
-९२.२१ लाख
Net profit margin
-१३,४१४.५०%
२०६.५५%
-६२१.२५%
-१,१४२.६३%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-२६.२१ लाख
-२६.४६ लाख
-२३.४६ लाख
-१८.०९ लाख
Net interest expenses
-२६.२१ लाख
-२६.४६ लाख
-२३.४६ लाख
-१८.०९ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.३९ करोड
-१.२८ करोड
-१.०१ करोड
-१.०८ करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू